Abstract

Fresh osteochondral allograft (OCA) transplantation has more than a 100-year clinical history. Many clinical and basic scientific studies have been performed with the result that allografting is now part of the cartilage repair paradigm for the treatment of chondral or osteochondral lesions. In the knee joint, allografting has also been successfully used in complex joint reconstruction for the treatment of osteonecrosis , fracture malunion , and selected cases of osteoarthritis . Unlike many other cartilage repair techniques, OCAs have the ability to restore mature, hyaline articular cartilage to the affected area. By virtue of their composite structure (cartilage and bone), allografts also can restore diseased or damaged bone often present in large or complex lesions. The surgical techniques of allografting are relatively straightforward, and many clinical studies have shown excellent results. OCAs do present the surgeon with unique and important differences from other cartilage repair techniques, such as limited allograft tissue availability and the potential for transmission of infectious disease from the graft or immunologic response by the recipient. Ongoing investigations continue to clarify the indications, surgical techniques, and clinical outcomes of fresh OCAs.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.